A monoterpenoid dihydrochalcone derivative isolated from Conamomum rubidum sensitizes erlotinib-mediated lung cancer cell death by suppressing STAT3/Bcl-2 signaling
Medicine in Drug Discovery · 2026-05 · 30 · 100254
DOI: 10.1016/j.medidd.2026.100254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine in Drug Discovery, 2026-05. Verfasst von Iksen Iksen und 6 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation, Chulalongkorn University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Thailand Science Research and Innovation
- Chulalongkorn University
Zitieren
APA
Iksen, I., Jitsayreerat, C., Klanbunchum, C., Nguyen, H. M., Hoang, H. N. T., Ho, D. V., & Pongrakhananon, V. (2026). A monoterpenoid dihydrochalcone derivative isolated from Conamomum rubidum sensitizes erlotinib-mediated lung cancer cell death by suppressing STAT3/Bcl-2 signaling. Medicine in Drug Discovery, 30, 100254. https://doi.org/10.1016/j.medidd.2026.100254
Vancouver
Iksen I, Jitsayreerat C, Klanbunchum C, Nguyen HM, Hoang HNT, Ho DV, et al. A monoterpenoid dihydrochalcone derivative isolated from Conamomum rubidum sensitizes erlotinib-mediated lung cancer cell death by suppressing STAT3/Bcl-2 signaling. Medicine in Drug Discovery. 2026;30:100254. doi:10.1016/j.medidd.2026.100254
BibTeX
@article{Iksen2026,
author = {Iksen, Iksen and Jitsayreerat, Chayaporn and Klanbunchum, Chavisa and Nguyen, Hien Minh and Hoang, Hanh Nhu Thi and Ho, Duc Viet and Pongrakhananon, Varisa},
title = {A monoterpenoid dihydrochalcone derivative isolated from Conamomum rubidum sensitizes erlotinib-mediated lung cancer cell death by suppressing STAT3/Bcl-2 signaling},
journal = {Medicine in Drug Discovery},
year = {2026},
volume = {30},
pages = {100254},
doi = {10.1016/j.medidd.2026.100254}
}
EUVIMED